Reglan (metoclopramide) is used to treat nausea, though not always as a standalone anti-nausea drug. Its FDA-approved uses are for diabetic gastroparesis and gastroesophageal reflux, both of which commonly cause nausea as a primary symptom. It also works directly against nausea in other settings, including migraine-related nausea and chemotherapy-induced nausea, where it may be prescribed off-label.
What Reglan Is Approved to Treat
The FDA has approved Reglan for two specific conditions. The first is diabetic gastroparesis, a condition where the stomach empties too slowly, causing nausea, vomiting, bloating, and feeling full after small meals. The second is gastroesophageal reflux that hasn’t responded to other treatments. In both cases, nausea relief is a core benefit of the medication. The American Gastroenterological Association recommends metoclopramide as a treatment option for gastroparesis symptoms.
Reglan also has a well-documented direct effect on nausea itself. In clinical trials for migraine, metoclopramide reduced both pain and nausea independently, meaning the nausea relief wasn’t just a side effect of pain going away. It was a direct action of the drug. That said, for general nausea unrelated to gastroparesis or reflux, other medications like ondansetron are more commonly prescribed first.
How Reglan Stops Nausea
Reglan works in two ways. First, it blocks dopamine receptors in the brain, specifically in the area that triggers nausea and vomiting. This is the same general mechanism used by some anti-psychotic medications, though Reglan is much milder. Second, it speeds up the movement of food through the stomach and into the small intestine. This combination is why it’s particularly effective for nausea caused by a sluggish stomach: it calms the nausea signal in the brain while also fixing the physical problem causing it.
The drug also has some activity against serotonin receptors, which play a role in gut motility and the vomiting reflex, though this effect is secondary to the dopamine-blocking action.
How Quickly It Works
The speed depends on how you receive the medication. Given intravenously in a hospital or emergency room, Reglan starts working within 1 to 3 minutes. An intramuscular injection takes 10 to 15 minutes. The oral tablet, which is the most common form for outpatient use, takes 30 to 60 minutes to kick in, with peak levels in the blood occurring 1 to 2 hours after a dose. The effects last about 1 to 2 hours regardless of how it’s given.
Typical Dosing
For gastroparesis, the standard dose is 10 mg taken 30 minutes before each meal and at bedtime, up to a maximum of 40 mg per day. Treatment courses typically run 2 to 8 weeks. For reflux, doses range from 10 to 15 mg before meals and at bedtime, with a higher daily ceiling of 60 mg, for 4 to 12 weeks. Single doses of up to 20 mg can also be used on an as-needed basis before situations that tend to provoke reflux symptoms.
The 30-minute-before-meals timing matters. It gives the drug time to start working before food enters the stomach, maximizing its ability to speed digestion and prevent nausea from building.
Side Effects to Know About
Because Reglan blocks dopamine receptors, it can cause movement-related side effects that range from uncomfortable to serious. The milder ones include drowsiness and restlessness (a jittery, can’t-sit-still feeling called akathisia). Some people experience muscle stiffness, involuntary muscle contractions, or tremors. These effects can start within hours or days of beginning the medication and typically resolve once it’s stopped.
The more concerning risk is tardive dyskinesia, a condition involving involuntary facial movements like lip-smacking, tongue thrusting, and grimacing. Unlike the short-term movement side effects, tardive dyskinesia develops after prolonged use (months or years) and can be permanent, even after stopping the drug. This risk is the reason Reglan carries the FDA’s most serious warning, a black box warning, and why treatment is capped at 12 weeks. The FDA label states that use beyond 12 weeks “should be avoided in all but rare cases where therapeutic benefit is thought to outweigh the risk.”
Older adults, women, and people with diabetes appear to face a higher risk of tardive dyskinesia, which is notable since diabetic gastroparesis is one of Reglan’s primary uses.
How Reglan Compares for Nausea
In a clinical trial comparing treatments for migraine-related nausea, 46% of patients treated with metoclopramide achieved clinically meaningful improvement, compared to 29% with placebo. That’s a real benefit, though another anti-nausea medication in the same trial (prochlorperazine) performed better at 82%. Metoclopramide did outperform ibuprofen for nausea relief specifically.
For gastroparesis-related nausea, Reglan holds a stronger position. It remains one of the only FDA-approved oral medications for this condition, and the American Gastroenterological Association continues to recommend it. The challenge is that many people with gastroparesis need long-term treatment, which conflicts with the 12-week safety limit. This often means using Reglan in short courses, then taking breaks or switching to other approaches.
Who Should Not Take Reglan
Reglan is not safe for people with certain conditions. Because it increases stomach and intestinal movement, it should not be used when that movement could cause harm, such as in cases of bowel obstruction, perforation, or gastrointestinal bleeding. People with Parkinson’s disease or other movement disorders should avoid it, since blocking dopamine can worsen their symptoms. Those with a history of seizures face an elevated risk as well. Anyone who has had tardive dyskinesia from any medication should not take Reglan.
The drug also interacts with the body’s dopamine system broadly enough that combining it with certain psychiatric medications, particularly older antipsychotics that also block dopamine, increases the risk of movement side effects significantly.